Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

What You Need to Know Ahead of Eli Lilly's Earnings Release

Eli Lilly and Company (LLY), headquartered in Indiana, is a major pharmaceutical firm with a diverse product lineup and a robust pipeline. Its key pharmaceutical categories include neuroscience, diabetes, oncology, and immunology, and the company commands an impressive market cap of $814.9 billion. The leading drug manufacturer plans to release its Q2 earnings for fiscal 2024 on Thursday, Aug. 8.

Ahead of the event, analysts expect Eli Lilly to report a profit of $2.66 per share, up 26.1% from $2.11 per share in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of the last four quarters.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.